Studies Suggest More Flexibility in Treating Advanced Colorectal Cancer
The results of two new large European clinical trials challenge the conventional thinking on the initial treatment of patients with advanced colorectal cancer, particularly those undergoing treatment almost strictly for palliative purposes, the studies' leaders say.
Published in the July 14 Lancet, the trials' results suggest that using either fluorouracil or capecitabine as single agents for first-line treatment in this patient population is no less effective and potentially less toxic than using a combination of two chemotherapy drugs, as is commonly recommended in the United States and Europe. Read more
Tackling Cancer Care Disparities in the Community
The theme of this issue of the NCI Cancer Bulletin is cancer health disparities, in conjunction with NCI's Cancer Health Disparities Summit 2007 held last week.
The summit convened a transdisciplinary cadre of more than 700 cancer health disparities investigators, health care providers, community partners, program managers, project staff, and civic leaders from across the country. NCI grantees from such programs as the Community Networks Program and the Patient Navigation Research Program were at the forefront of the 3-day event, discussing collaborations and partnerships, communications and bioinformatics, community engagement, managing and sustaining programs, and training and education. Read more